华仁药业
(300110)
| 流通市值：39.78亿 | | | 总市值：39.84亿 |
| 流通股本：11.80亿 | | | 总股本：11.82亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,215,927,751.99 | 829,046,309.5 | 403,241,817.91 | 1,619,492,335.02 |
| 营业收入 | 1,215,927,751.99 | 829,046,309.5 | 403,241,817.91 | 1,619,492,335.02 |
| 二、营业总成本 | 1,032,296,689.68 | 720,954,485.3 | 349,719,742.04 | 1,397,144,045.46 |
| 营业成本 | 682,901,948.96 | 479,424,945.73 | 235,230,844.32 | 918,710,352.89 |
| 税金及附加 | 18,136,148.5 | 12,571,875.5 | 6,924,890.03 | 26,754,773.8 |
| 销售费用 | 163,089,193.12 | 116,290,006.12 | 55,041,516.89 | 225,447,757.88 |
| 管理费用 | 73,912,589.73 | 49,861,726.28 | 22,877,441.69 | 105,461,781.28 |
| 研发费用 | 43,426,283.82 | 28,557,990.51 | 14,860,243.45 | 55,301,520.99 |
| 财务费用 | 50,830,525.55 | 34,247,941.16 | 14,784,805.66 | 65,467,858.62 |
| 其中:利息费用 | 47,388,034.96 | 32,220,353.16 | 14,768,332.67 | 64,161,428.52 |
| 其中:利息收入 | 745,028.79 | 562,950.93 | 244,841.21 | 4,769,347.17 |
| 加:投资收益 | 301,571.34 | 301,571.34 | - | -1,386,234.72 |
| 资产处置收益 | 4,592,138.36 | 4,599,916.21 | - | 13,864,046.05 |
| 资产减值损失(新) | 365,655.33 | -535,924.07 | - | -11,589,280.05 |
| 信用减值损失(新) | -37,610,185.56 | -25,090,321.37 | -7,798,196.64 | -44,791,195.69 |
| 其他收益 | 3,468,830.26 | 1,068,552.37 | 955,678.09 | 20,045,121.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 154,749,072.04 | 88,435,618.68 | 46,679,557.32 | 198,490,746.68 |
| 加:营业外收入 | 3,165,356 | 2,782,963.81 | 136,317.71 | 12,659,140.84 |
| 减:营业外支出 | 700,338.97 | 500,829.83 | 64,120.09 | 5,290,796.66 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 157,214,089.07 | 90,717,752.66 | 46,751,754.94 | 205,859,090.86 |
| 减:所得税费用 | 16,563,098.56 | 6,279,569.67 | 4,881,094.44 | 24,521,447.62 |
| 六、净利润 | 140,650,990.51 | 84,438,182.99 | 41,870,660.5 | 181,337,643.24 |
| 持续经营净利润 | 140,650,990.51 | 84,438,182.99 | 41,870,660.5 | 181,337,643.24 |
| 归属于母公司股东的净利润 | 137,083,571.59 | 82,281,868.89 | 41,102,886.41 | 180,815,847.76 |
| 少数股东损益 | 3,567,418.92 | 2,156,314.1 | 767,774.09 | 521,795.48 |
| (一)基本每股收益 | 0.12 | 0.07 | 0.03 | 0.15 |
| (二)稀释每股收益 | 0.12 | 0.07 | 0.03 | 0.15 |
| 九、综合收益总额 | 140,650,990.51 | 84,438,182.99 | 41,870,660.5 | 181,337,643.24 |
| 归属于母公司股东的综合收益总额 | 137,083,571.59 | 82,281,868.89 | 41,102,886.41 | 180,815,847.76 |
| 归属于少数股东的综合收益总额 | 3,567,418.92 | 2,156,314.1 | 767,774.09 | 521,795.48 |
| 公告日期 | 2023-10-25 | 2023-08-26 | 2023-04-20 | 2023-03-25 |
| 审计意见(境内) | | | | 标准无保留意见 |